BioCryst
Trade BioCryst 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
Stock Snapshot
With a market cap of 1.61B, BioCryst(BCRX) trades at $7.62. The stock has a price-to-earnings ratio of -162.79.
On 2025-12-26, BioCryst(BCRX) stock moved within a range of $7.53 to $7.69. With shares now at $7.62, the stock is trading +1.2% above its intraday low and -0.9% below the session's peak.
Trading volume for BioCryst(BCRX) stock has reached 961.88K, versus its average volume of 3.79M.
Over the past 52 weeks, BioCryst(BCRX) stock has traded between a high of $11.31 and a low of $6.00.
Over the past 52 weeks, BioCryst(BCRX) stock has traded between a high of $11.31 and a low of $6.00.
BCRX News
BioCryst Pharmaceuticals previously announced that the FDA approved its New Drug Application for an oral pellet formulation of once-daily ORLADEYO (berotralstat...
Claim 70% Off TipRanks This Holiday Season An announcement from Astria Therapeutics ( (ATXS) ) is now available. On October 14, 2025, Astria Therapeutics ente...